FABP-1 is relatively over-expressed in patients with simple steatosis compared with those with obesity; however, throughout the NAFLD stages, it was observed that FABP-1 was significantly under-expressed in patients with mild and progressive NASH [60]. The gene discussed is FABP1; the disease is metabolic dysfunction-associated steatotic liver disease.